Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer.

[1]  Edward Clouser,et al.  Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. , 2010, International journal of radiation oncology, biology, physics.

[2]  G. Videtic,et al.  The Role of Stereotactic Body Radiotherapy in the Management of Non-Small Cell Lung Cancer: An Emerging Standard for the Medically Inoperable Patient? , 2010, Current Oncology Reports.

[3]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[4]  Tarek Mekhail,et al.  A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  C. Reddy,et al.  Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  Richard J Stephens,et al.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Hiroki Shirato,et al.  STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .

[8]  T. Waddell,et al.  Surgery for small-cell lung cancer. , 2006, Seminars in thoracic and cardiovascular surgery.

[9]  Andrew K Stewart,et al.  Patterns of surgical care of lung cancer patients. , 2005, The Annals of thoracic surgery.

[10]  P. Goldstraw,et al.  Surgery for small cell lung cancer. , 2004, Hematology/oncology clinics of North America.

[11]  Cancer Therapy Evaluation Program.  Common Terminology Criteria for Adverse Events v3.0 (CTCAE) , 2003 .

[12]  R. Komaki,et al.  Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. , 1999, The New England journal of medicine.

[13]  Urschel Jd.  Surgical treatment of peripheral small cell lung cancer. , 1997 .